ASRS
AVIR icon

Arizona State Retirement System’s Atea Pharmaceuticals AVIR Stock Holding History

Arizona State Retirement System’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-21,719
Closed -$72.8K – 2183
2023
Q1 		$72.8K Buy
21,719
+575
+3% +$2.33K ﹤0.01% 2153
2022
Q4 		$102K Buy
21,144
+781
+4% +$3.95K ﹤0.01% 2102
2022
Q3 		$116K Buy
20,363
+94
+0.5% +$720 ﹤0.01% 2061
2022
Q2 		$144K Buy
+20,269
New +$138K ﹤0.01% 2036

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arizona State Retirement System's AVIR Position: Q2 2023 in Review

Arizona State Retirement System sold out of Atea Pharmaceuticals (AVIR) in Q2 2023, closing a stake of 21,719 shares — an estimated $72.8K sold.

Arizona State Retirement System first reported a position in AVIR in Q2 2022 and held it in 4 quarters. The position peaked at $144K in Q2 2022. 133 funds tracked by Wall St. Rank hold AVIR as of Q2 2023.

  • Arizona State Retirement System reported no remaining Atea Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Arizona State Retirement System sold 21,719 Atea Pharmaceuticals shares in Q2 2023, an estimated $72.8K.
  • Arizona State Retirement System first reported a position in Atea Pharmaceuticals in Q2 2022 and held it in 4 quarters.
  • Arizona State Retirement System's Atea Pharmaceuticals position peaked at $144K in Q2 2022.
  • 133 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2023.

Based on Arizona State Retirement System's 13F filing for Q2 2023, filed 1 Aug 2023.